Cargando…

The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper

Muscle wasting is one of the main causes for exercise intolerance and ventilatory inefficiency in patients with heart failure and a strong predictor of frailty and reduced survival. The prevalence of sarcopenia is at least 20% in patients with heart failure. Patients with heart failure often have su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bielecka-Dabrowa, Agata, Banach, Maciej, Wittczak, Andrzej, Cicero, Arrigo F.G., Kallel, Amani, Kubilius, Raimondas, Mikhailidis, Dimitri P., Sahebkar, Amirhossein, Pantea Stoian, Anca, Vinereanu, Dragos, Penson, Peter E., von Haehling, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2023
Materias:	State of the Art Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408027/ https://www.ncbi.nlm.nih.gov/pubmed/37560745 http://dx.doi.org/10.5114/aoms/167799

Ejemplares similares

Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
por: Penson, Peter E., et al.
Publicado: (2022)

Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview
por: Michalska-Kasiczak, Marta, et al.
Publicado: (2018)

Resveratrol and cognitive decline: a clinician perspective
por: Cicero, Arrigo F.G., et al.
Publicado: (2019)

Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
por: Cicero, Arrigo F. G., et al.
Publicado: (2021)

Menopause and women’s cardiovascular health: is it really an obvious relationship?
por: Ryczkowska, Kamila, et al.
Publicado: (2022)

Curcumin - The Nutraceutical With Pleiotropic Effects? Which Cardiometabolic Subjects Might Benefit the Most?
por: Surma, Stanisław, et al.
Publicado: (2022)

The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy – 5-year follow-up
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2013)

Left Ventricular Diastolic Dysfunction as Predictor of Unfavorable Prognosis After ESUS
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2021)

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
por: Cicero, Arrigo F.G., et al.
Publicado: (2017)

Exosomes as nanocarriers for siRNA delivery: paradigms and challenges
por: Shahabipour, Fahimeh, et al.
Publicado: (2016)

The Importance of Optimal Hydration in Patients with Heart Failure—Not Always Too Much Fluid
por: Wittczak, Andrzej, et al.
Publicado: (2023)

Nutrition, Nutraceuticals and Bioactive Compounds in the Prevention and Fight against Inflammation
por: Surma, Stanisław, et al.
Publicado: (2023)

The mechanisms of atrial fibrillation in hyperthyroidism
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2009)

Nutraceuticals and Hypertensive Disorders in Pregnancy: The Available Clinical Evidence
por: Fogacci, Silvia, et al.
Publicado: (2020)

2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy
por: Banach, Maciej, et al.
Publicado: (2022)

The role of statins in lung cancer
por: Amin, Fatemeh, et al.
Publicado: (2021)

Application of polyunsaturated fatty acids in internal medicine: beyond the established cardiovascular effects
por: Cicero, Arrigo F.G, et al.
Publicado: (2012)

Pathophysiological mechanisms of statin‐associated myopathies: possible role of the ubiquitin‐proteasome system
por: Sahebkar, Amirhossein, et al.
Publicado: (2020)

The effect of curcumin on hypoxia in the tumour microenvironment as a regulatory factor in cancer
por: Zahedi, Mohammad, et al.
Publicado: (2023)

Arterial Stiffness and Indices of Left Ventricular Diastolic Dysfunction in Patients with Embolic Stroke of Undetermined Etiology
por: Gąsiorek, Paulina, et al.
Publicado: (2019)

Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications
por: Bikiewicz, Agata, et al.
Publicado: (2021)

CETP inhibition in the REVEAL trial: could we aim higher?
por: Sahebkar, Amirhossein, et al.
Publicado: (2020)

Nutraceuticals for the Control of Dyslipidaemias in Clinical Practice
por: Penson, Peter E., et al.
Publicado: (2021)

Correction to: Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2020)

Natural approaches in metabolic syndrome management
por: Patti, Angelo Maria, et al.
Publicado: (2017)

Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study
por: Cicero, Arrigo F.G., et al.
Publicado: (2015)

The effects of statins on the function and differentiation of blood cells
por: Chamani, Sajjad, et al.
Publicado: (2022)

Impact of physical activity on inflammation: effects on cardiovascular disease risk and other inflammatory conditions
por: Ertek, Sibel, et al.
Publicado: (2012)

Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology
por: Ertek, Sibel, et al.
Publicado: (2013)

Factors and Prognostic Significance of Impaired Exercise Tolerance in Women over 40 with Arterial Hypertension
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2021)

Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology
por: Anker, Markus S., et al.
Publicado: (2013)

The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia
por: Penson, Peter E., et al.
Publicado: (2020)

Dietary and nutraceutical approach to type 2 diabetes
por: Derosa, Giuseppe, et al.
Publicado: (2014)

Successful complex percutaneous intervention in patient with Fontan circulation and severe heart failure: A case report
por: Wittczak, Andrzej, et al.
Publicado: (2023)

Statins as anti-pyroptotic agents
por: Khalifeh, Masoomeh, et al.
Publicado: (2021)

The outcomes of hypertension treatment depending on gender in patients over 40 years of age
por: Paduszyńska, Aleksandra, et al.
Publicado: (2021)

A Randomized, Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO(®)) on LDL Cholesterol Levels and Lipid Pattern in Subjects with Sub-Optimal Blood Cholesterol Levels (NATCOL Study)
por: Cicero, Arrigo F.G., et al.
Publicado: (2020)

Randomised comparison of zofenopril and ramipril plus acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a post hoc analysis of the SMILE-4 Study in patients according to levels of left ventricular ejection fraction at entry
por: Borghi, Claudio, et al.
Publicado: (2015)

Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditions
por: Penson, Peter E., et al.
Publicado: (2018)

Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a06nuptr3lpramjm7h5e60g7jf